Until now, molecular-level DNA circuits have mainly been used for simple tasks, such as detecting the presence of ...
Morning Overview on MSN
Long-read RNA sequencing tool boosts rare-disease diagnoses missed by DNA tests
For years, two siblings with the distinctive facial features of Treacher Collins syndrome had no genetic explanation for ...
Mayo Clinic scientists are exploring an unusual but promising strategy to treat one of the deadliest bile duct cancers by turning milk into a microscopic delivery system for gene therapy. Their work ...
After a decade of clinical assessments failed to meet DSM-5 criteria, a chromosomal microarray revealed the genetic truth behind a complex neurodevelopmental presentation. This question addresses a ...
PORTLAND, Ore. – Drug delivery researchers have vastly improved the potential of genetic therapies by overcoming the challenge of consistently getting genes and gene-editing tools where they need to ...
SAN DIEGO, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional ...
HOUSTON, TX, UNITED STATES, February 24, 2026 /EINPresswire.com/ — FamilyTreeDNA, the company that pioneered the genetic genealogy industry, today announced a ...
Growing revenues from Casgevy will help CRISPR Therapeutics fund the development of its pipeline therapies. The gene-editing biotech isn't profitable yet. CRISPR Therapeutics has a deep pipeline of ...
Researchers have demonstrated that lipid nanoparticles can package and deliver an entire therapeutic gene along with gene-editing machinery - a combination of large, complex components that non-viral ...
When Genenta Science listed on the Nasdaq at the tail end of 2021, the Milan-based biotech was squarely focused on its pipeline of cell-based gene therapies. But, four years later, the company is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results